Bachoco (IBA) Rating Lowered to Hold at Zacks Investment Research

Bachoco (NYSE:IBA) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

According to Zacks, “INDUSTRIAS BACHOO began its operations in 1952 in the state of Sonora, Mexico, and has since grown into the country’s undisputed leader in poultry production and one of the wold’s top ten producer. It also produces and distributes eggs, swine and balanced feed. It is a vertically integrated company, with a nationwide distribution network and processing plants operating in conjunction with over 600 facilities located throughout Mexico. “

How to Become a New Pot Stock Millionaire

Shares of Bachoco stock opened at $61.83 on Thursday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.23 and a current ratio of 2.93. The company has a market capitalization of $3,181.00, a price-to-earnings ratio of 12.54 and a beta of 0.40. Bachoco has a one year low of $51.56 and a one year high of $67.61.

Bachoco (NYSE:IBA) last posted its earnings results on Wednesday, January 31st. The company reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.88. Bachoco had a return on equity of 14.52% and a net margin of 8.35%. The firm had revenue of $765.00 million for the quarter, compared to analysts’ expectations of $46.16 million. equities analysts expect that Bachoco will post 4.35 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. New York State Common Retirement Fund increased its stake in shares of Bachoco by 10.2% during the third quarter. New York State Common Retirement Fund now owns 24,053 shares of the company’s stock valued at $1,600,000 after buying an additional 2,228 shares during the period. Comerica Bank purchased a new position in shares of Bachoco during the fourth quarter valued at approximately $244,000. Deutsche Bank AG purchased a new position in shares of Bachoco during the fourth quarter valued at approximately $235,000. Sarasin & Partners LLP increased its stake in shares of Bachoco by 5.6% during the fourth quarter. Sarasin & Partners LLP now owns 95,000 shares of the company’s stock valued at $5,444,000 after buying an additional 5,000 shares during the period. Finally, Allianz Asset Management GmbH increased its stake in shares of Bachoco by 3.6% during the third quarter. Allianz Asset Management GmbH now owns 189,506 shares of the company’s stock valued at $12,602,000 after buying an additional 6,528 shares during the period. 3.75% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Bachoco (IBA) Rating Lowered to Hold at Zacks Investment Research” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3337456/bachoco-iba-rating-lowered-to-hold-at-zacks-investment-research.html.

Bachoco Company Profile

Industrias Bachoco, SAB. de C.V., through its subsidiaries, operates as a poultry producer in Mexico and the United States. The company primarily engages in the breeding, processing, and marketing of chicken, eggs, swine, and balanced animal feed. It also offers value-added turkey and beef products; and produces and distributes medicines and vaccines for animal consumption.

Get a free copy of the Zacks research report on Bachoco (IBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Bachoco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bachoco and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Reata Pharmaceuticals  Raised to “Sell” at BidaskClub
Reata Pharmaceuticals Raised to “Sell” at BidaskClub
Territorial Bancorp  Stock Rating Lowered by BidaskClub
Territorial Bancorp Stock Rating Lowered by BidaskClub
VSE  Upgraded at BidaskClub
VSE Upgraded at BidaskClub
Credit Suisse Group Raises Snap  Price Target to $21.00
Credit Suisse Group Raises Snap Price Target to $21.00
Zacks Investment Research Lowers NVR  to Sell
Zacks Investment Research Lowers NVR to Sell
Bristol-Myers Squibb’s  Hold Rating Reiterated at Cowen
Bristol-Myers Squibb’s Hold Rating Reiterated at Cowen


© 2006-2018 Ticker Report. Google+.